United States Biotechnology & Medical Research

Trevena Inc (TRVN)

Track

Ticker: TRVN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Trevena Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 28 Jun 2022
Value US$941,473.72 | Price 396.44 | Shares 36,415 (+39.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-06-29 2022-06-28 S Sale
3.3
Shin Barry

SVP, CFO

Officer
36,415 +39.2%
396.44
US$941,474 		36,415 +39.2% 396.44 US$941,474
2021-06-28 2021-06-28 B Purchase
1.5
Bourdow Carrie L.

President & CEO

Executive Director
40,610 +42.0%
226.96
US$4,657,848 		40,610 +42.0% 226.96 US$4,657,848
2019-06-04 2019-05-31 B Purchase
2.6
Hamill John P.

VP Fin,Princ Fin&Acct Officer
92,743 +35.1%
42.17
US$227,258 		92,743 +35.1% 42.17 US$227,258
2019-02-05 2019-02-01 B Purchase
3.2
GOWEN MAXINE

President & CEO

Executive Director
50,000 +1250.0%
1.02
US$51,000 		50,000 +1250.0% 1.02 US$51,000
2019-02-04 2019-02-01 B Purchase
3.9
MOULDER LEON O JR
Non-Executive Director
100,000 +inf%
1.02
US$102,000 		100,000 +inf% 1.02 US$102,000
2018-03-23 2018-03-22 S Sale Habib Yacoub

SVP, Bus Dev & Corp Planning
5,000 -100.0%
1.76
US$8,800 		5,000 -100.0% 1.76 US$8,800
2017-02-14 2017-02-10 PlS Planned sale Lark Michael W.

Sr. VP, Research & CSO
23,699 -24.1%
8.00
US$189,592 		23,699 -24.1% 8.00 US$189,592
2016-11-10 2016-11-09 B Purchase Bourdow Carrie L.

SVP, Chief Commercial Officer

Officer
4,000 +800.0%
4.34
US$17,360 		4,000 +800.0% 4.34 US$17,360
2016-11-09 2016-11-07 B Purchase Habib Yacoub

SVP, Bus Dev & Corp Planning

Officer
5,000 +inf%
4.12
US$20,600 		5,000 +inf% 4.12 US$20,600
2016-11-09 2016-11-07 B Purchase GOWEN MAXINE

President & CEO

Executive Director
12,500 +312.5%
4.10
US$51,250 		12,500 +312.5% 4.10 US$51,250
2016-05-31 2016-05-27 B Purchase GOWEN MAXINE

President & CEO

Executive Director
14,084 +5.0%
7.08
US$99,715 		14,084 +5.0% 7.08 US$99,715
2016-05-31 2016-05-26 B Purchase GOWEN MAXINE

President & CEO

Executive Director
4,000 +inf%
7.20
US$28,800 		4,000 +inf% 7.20 US$28,800
2016-05-31 2016-05-26 B Purchase GOWEN MAXINE

President & CEO

Executive Director
4,000 +1.5%
7.19
US$28,760 		4,000 +1.5% 7.19 US$28,760
2014-12-15 2014-12-12 B Purchase Limongelli John M

Sr. VP,General Counsel & Secy

Officer
3,000 +33.3%
4.14
US$12,420 		3,000 +33.3% 4.14 US$12,420
2014-12-10 2014-12-10 B Purchase MOULDER LEON O JR Non-Executive Director
19,800 +65.6%
4.06
US$80,388 		19,800 +65.6% 4.06 US$80,388
2014-12-10 2014-12-10 B Purchase New Enterprise Associates 12, Limited Partnership Large shareholder
1,000,000 +26.2%
4.00
US$4,000,000 		1,000,000 +26.2% 4.00 US$4,000,000
2014-12-10 2014-12-10 B Purchase Lark Michael W.

Sr. VP, Research & CSO

Officer
5,000 +6.2%
4.00
US$20,000 		5,000 +6.2% 4.00 US$20,000
2014-12-10 2014-12-10 B Purchase Limongelli John M

Sr. VP,General Counsel & Secy

Officer
9,000 +inf%
4.00
US$36,000 		9,000 +inf% 4.00 US$36,000
2014-12-10 2014-12-10 B Purchase Soergel David

Sr. VP, Clinical Development

Officer
1,250 +4.6%
4.00
US$5,000 		1,250 +4.6% 4.00 US$5,000
2014-12-10 2014-12-10 B Purchase Alta Partners VIII, L.P. Large shareholder
500,000 +12.9%
4.00
US$2,000,000 		500,000 +12.9% 4.00 US$2,000,000
2014-12-10 2014-12-10 B Purchase Yanni Barbara Non-Executive Director
1,250 +inf%
4.00
US$5,000 		1,250 +inf% 4.00 US$5,000
2014-12-10 2014-12-10 B Purchase GOWEN MAXINE

President & CEO

Executive Director
8,000 +2.5%
4.00
US$32,000 		8,000 +2.5% 4.00 US$32,000
2014-12-10 2014-12-10 B Purchase DOUGHERTY MICHAEL R Non-Executive Director
7,000 +inf%
4.00
US$28,000 		7,000 +inf% 4.00 US$28,000
2014-12-10 2014-12-10 B Purchase Cuca Roberto

Sr. VP and CFO

Officer
25,000 +inf%
4.00
US$100,000 		25,000 +inf% 4.00 US$100,000
2014-12-10 2014-12-09 B Purchase MOULDER LEON O JR Non-Executive Director
30,200 +inf%
3.96
US$119,592 		30,200 +inf% 3.96 US$119,592
2014-08-18 2014-08-14 S Sale Polaris Venture Management Co. V, L.L.C. Large shareholder
354 -1.0%
6.04
US$2,138 		354 -1.0% 6.04 US$2,138
2014-08-18 2014-08-14 S Sale Polaris Venture Management Co. V, L.L.C. Large shareholder
243 -1.0%
6.04
US$1,468 		243 -1.0% 6.04 US$1,468
2014-08-18 2014-08-14 S Sale Polaris Venture Management Co. V, L.L.C. Large shareholder
690 -1.0%
6.04
US$4,168 		690 -1.0% 6.04 US$4,168
2014-08-18 2014-08-14 S Sale Polaris Venture Management Co. V, L.L.C. Large shareholder
35,415 -1.0%
6.04
US$213,907 		35,415 -1.0% 6.04 US$213,907
2014-08-15 2014-08-13 S Sale Polaris Venture Management Co. V, L.L.C. Large shareholder
55 -0.1%
6.12
US$337 		55 -0.1% 6.12 US$337
2014-08-15 2014-08-13 S Sale Polaris Venture Management Co. V, L.L.C. Large shareholder
38 -0.2%
6.12
US$233 		38 -0.2% 6.12 US$233
2014-08-15 2014-08-13 S Sale Polaris Venture Management Co. V, L.L.C. Large shareholder
107 -0.1%
6.12
US$655 		107 -0.1% 6.12 US$655
2014-08-15 2014-08-13 S Sale Polaris Venture Management Co. V, L.L.C. Large shareholder
5,500 -0.1%
6.12
US$33,660 		5,500 -0.1% 6.12 US$33,660
2014-02-07 2014-02-05 B Purchase Forest Laboratories Holdings Ltd Large shareholder
428,571 +14.5%
7.00
US$2,999,997 		428,571 +14.5% 7.00 US$2,999,997
2014-02-07 2014-02-05 B Purchase HealthCare Ventures VIII, L.P. Large shareholder
297,058 +13.8%
7.00
US$2,079,406 		297,058 +13.8% 7.00 US$2,079,406
2014-02-07 2014-02-05 B Purchase Alta Partners VIII, L.P. Large shareholder
472,410 +13.8%
7.00
US$3,306,870 		472,410 +13.8% 7.00 US$3,306,870
2014-02-07 2014-02-05 B Purchase Polaris Venture Management Co. V, L.L.C. Large shareholder
472,405 +14.1%
7.00
US$3,306,835 		472,405 +14.1% 7.00 US$3,306,835
2014-02-07 2014-02-05 B Purchase New Enterprise Associates 12, Limited Partnership Large shareholder
472,410 +14.1%
7.00
US$3,306,870 		472,410 +14.1% 7.00 US$3,306,870
Explore more

More insider trading research around Trevena Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America